Technology

Latest News


The European Medicines Agency (EMA) has started a review of human papillomavirus (HPV) vaccines to further clarify aspects of their safety profile.HPVvaccines have been used in around 72 million people worldwide to prevent cervical cancer and other cancers and conditions caused by HPV. Cervical cancer is the fourth most common cause of cancer death in women worldwide.

All indications are that the July 2016 deadline for transition from Europe's eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) to the new Identification of Medicinal Products (IDMP) is not achievable. Sophie Daniels reports.